Search
Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.
Membership is a widely accepted mark of excellence in science and considered one of the highest honors a scientist can receive.
Targeting this signal with drugs might be one way to stop cancers from spreading.
Researchers have discovered uncanny similarities between cells found in brain tumors and a type of stem cell that’s important for building the brain during fetal development.
Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.
Memorial Sloan Kettering’s 37th annual academic Convocation and the fifth Louis V. Gerstner Graduate School of Biomedical Sciences Commencement shared the spotlight on May 19.
A drug combination that halts tumor cell division can stir the immune system into taking action.
MSK’s Convocation and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences Commencement celebrate the achievements of young scientists.
Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.
A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.